Just over a year ago, TrialSite introduced the exploits of the fake principal investigator named Sani Anwar, owner of Zain Research and Mid-Columbia Research, to a much wider audience. Industry publications and online media, for the most part, shunned the story. It’s as if the egregious criminal breach raised a collective industry embarrassment. The 41-year-old finally had justice served: 47 counts of fraud and drug-related charges and 28 years in prison. Back in November, TrialSite reported the defendant was found guilty of defrauding pharmaceutical companies out of several million dollars as they entered into contracts with his deceptive trial site operations for conducting clinical trials. Why the pharmaceutical company sponsors or their contract research organizations (CROs) didn’t identify the red flags earlier to stop this fraud cannot be certain. But suffice to say some very large and sophisticated pharmaceutical companies, and at least one prominent CRO, were completely duped, and in the process, clinical trial participants were put in harm’s way.
“Goodfellas meets Catch Me If you Can” in Clinical Research
TrialSite noted, “Hollywood could not have created...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).